sodium nitroprusside NDC 70436-028

NDC codes

FDA NDC Directory

Product NDC (as listed)70436-028Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70436-0028Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70436-028-80	70436002880	1 VIAL in 1 CARTON (70436-028-80) / 2 mL in 1 VIALMarketed from Oct 15, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): sodium nitroprusside
Generic name (nonproprietary): sodium nitroprusside
Active ingredients: Sodium nitroprusside — 50 mg/2mL
Dosage form: Injection, Solution, Concentrate
Route: Intravenous
Labeler: Slate Run Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214199
Marketing start: Oct 15, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Vasodilation (Physiologic effect)
Identifiers: Product ID 70436-028_b17353da-2c56-d579-e053-2995a90a8227SPL ID b17353da-2c56-d579-e053-2995a90a8227SPL set ID 01dfae56-3d9b-448a-84a7-03a54a533eb1RxCUI 240793UNII EAO03PE1TCUPC 0370436028801
Pharmacologic class: Vasodilator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470436002880 followed by a unit qualifier and the quantity

Package 70436-0028-80. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 15, 2020. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. Concomitant longer-acting antihypertensive medication should be administered so that the duration of treatment with sodium nitroprusside can be minimized. Sodium nitroprusside is also indicated for producing controlled hypotension in order to reduce bleeding during surgery. Sodium nitroprusside is also indicated for the treatment of acute congestive heart failure.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214199

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214199
Product	Strength	Form · route	Labeler	Product NDC
sodium nitroprusside	Sodium nitroprusside 50 mg/2mL	Injection, Solution, ConcentrateIntravenous	Hainan Poly Pharm. Co., Ltd.	14335-131